First-quarter share price successes
For more on Q1 2019 share price performances see: Topsy turvy times for industry’s mid and small cap stocks in the first quarter and US big biotechs lag in the opening quarter of the year
Share This Article
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.